Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial

BACKGROUND: Combining the antibiotic azithromycin and hydroxychloroquine induces airway immunomodulatory effects, with the latter also having in vitro antiviral properties. This may improve outcomes in patients hospitalised for coronavirus disease 2019 (COVID-19). METHODS: Placebo-controlled double-...

詳細記述

保存先:
書誌詳細
出版年:Eur Respir J
主要な著者: Sivapalan, Pradeesh, Ulrik, Charlotte Suppli, Lapperre, Therese Sophie, Bojesen, Rasmus Dahlin, Eklöf, Josefin, Browatzki, Andrea, Wilcke, Jon Torgny, Gottlieb, Vibeke, Håkansson, Kjell Erik Julius, Tidemandsen, Casper, Tupper, Oliver, Meteran, Howraman, Bergsøe, Christina, Brøndum, Eva, Bødtger, Uffe, Bech Rasmussen, Daniel, Graff Jensen, Sidse, Pedersen, Lars, Jordan, Alexander, Priemé, Helene, Søborg, Christian, Steffensen, Ida E., Høgsberg, Dorthe, Klausen, Tobias Wirenfeldt, Frydland, Martin Steen, Lange, Peter, Sverrild, Asger, Ghanizada, Muhzda, Knop, Filip K., Biering-Sørensen, Tor, Lundgren, Jens D., Jensen, Jens-Ulrik Stæhr
フォーマット: Artigo
言語:Inglês
出版事項: European Respiratory Society 2022
主題:
Original Research Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8186006/
https://ncbi.nlm.nih.gov/pubmed/34083403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00752-2021
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料